Literature DB >> 10583513

Acquired von Willebrand syndrome--report of 10 cases and review of the literature.

I C Nitu-Whalley1, C A Lee.   

Abstract

Acquired von Willebrand syndrome (AvWS) is a rare bleeding disorder with clinical and laboratory features closely resembling hereditary von Willebrand disease (vWD), arising in previously haemostatically normal individuals. We present a retrospective review of 10 cases with AvWS diagnosed over 17 years. The severity of the bleeding tendency varied from mild to severe forms. Multimers electrophoresis showed that 8/10 patients had a normal pattern similar to type 1 vWD, 1/10 had a type 2A vWD pattern (with absence of high and intermediate molecular weight multimers) and 1/10 had a type 3 vWD pattern. An inhibitor screen was performed in 6/10 patients and autoantibodies against von Willebrand factor were found in only two cases. The underlying cause/associated conditions were identified in 8/10 patients. Treatment of the bleeding diathesis was successfully achieved with desmopressin or clotting factor concentrates. Resolution of underlying hypothyroidism (in two cases) and multiple myeloma (in one case) led to normalization of the coagulation parameters. The report on this cohort of 10 patients with AvWS illustrates the complexity of AvWS and its multifactorial aetiology. A brief review of the recent literature on AvWS is also presented, with emphasis on the current opinions in pathogenesis and treatment. Acquired von Willebrand syndrome (AvWS) is an acquired bleeding disorder, characterized by a phenotype similar to the inherited von Willebrand disease (vWD), with a prolonged bleeding time and low plasma levels of factor VIII - von Willebrand factor (vWF) measurements. It occurs in patients with no family history of vWD, who present with recent onset of bleeding symptoms. AvWS appears to be associated mainly with lymphoproliferative disorders, immunological conditions and neoplasia. AvWS is a rare condition and it is difficult to conduct prospective studies, therefore it is important to document the experience with such cases. The aim of this paper is first, to report 10 cases of AvWS identified at our Haemophilia Centre during the past 17 years. Second, to present a brief review of the recent literature on AvWS - outlining the salient features, associated disorders, mechanisms of acquisition and the available options of treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10583513     DOI: 10.1046/j.1365-2516.1999.00340.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  6 in total

1.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

Review 2.  Hemostasis and thyroid diseases revisited.

Authors:  M Franchini
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

Review 3.  Thyroid hormones and cardiovascular disease.

Authors:  Avais Jabbar; Alessandro Pingitore; Simon H S Pearce; Azfar Zaman; Giorgio Iervasi; Salman Razvi
Journal:  Nat Rev Cardiol       Date:  2016-11-04       Impact factor: 32.419

4.  Myxedema coma: a new look into an old crisis.

Authors:  Vivek Mathew; Raiz Ahmad Misgar; Sujoy Ghosh; Pradip Mukhopadhyay; Pradip Roychowdhury; Kaushik Pandit; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  J Thyroid Res       Date:  2011-09-15

5.  Acquired von Willebrand Disease Associated with Monoclonal Gammopathy of Unknown Significance.

Authors:  Sijan Basnet; Catherine Lin; Rashmi Dhital; Izza Mir; Elan Mohanty; Biswaraj Tharu; Sushil Ghimire; Dilli Ram Poudel
Journal:  Case Rep Oncol Med       Date:  2017-11-01

6.  Administration of plasma-derived coagulation factor VIII during the perioperative period of mastectomy for breast cancer with acquired von Willebrand syndrome.

Authors:  Ritsuko Sasaki; Yoshiya Horimoto; Ju Mizuno; Yoko Edahiro; Tsukasa Ohmori; Norio Komatsu; Mitsue Saito
Journal:  Surg Case Rep       Date:  2018-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.